:: Volume 22, Issue 4 (10-2024) ::
Int J Radiat Res 2024, 22(4): 1085-1089 Back to browse issues page
Investigating the radiation dose to the cervical and thoracic esophagus from post-mastectomy adjuvant radiation therapy in breast cancer
S. Aflatoonian , S. Yazdani , S. Zare , M. Ilaghi , M. Bahador
Abstract:   (1073 Views)
Background: Radiation therapy (RT) plays a crucial role in breast cancer management. However, RT may inadvertently expose neighboring organs to potential adverse effects. This study aimed to quantitatively analyze the radiation dose delivered to the cervical and thoracic esophagus during RT, focusing on patients undergoing post-mastectomy adjuvant RT. Materials and Methods: This cross-sectional study included 100 breast cancer patients who underwent post-mastectomy adjuvant RT to the chest wall and supraclavicular field (SCF) using 3-Dimensional Conformal Radiation Therapy (3DCRT). The dosimetric parameters, including mean dose (Dmean), V5, V10 and V30, were estimated from dose-volume histogram (DVH) data for the cervical and thoracic esophagus. Results: The mean age of the patients was 54.01 (± 11.62) years. The Dmean (± SD) for the thoracic and cervical esophagus were 1.15 (± 0.52) and 3.06 (± 2.09), respectively, with statistically significant different doses between the thoracic and cervical esophagus (P-value < 0.001). The V5, V10, and V30 for the thoracic esophagus were zero; however, the V5, V10 and V30 for the cervical esophagus were 7.07 (± 15.83), 2.29 (± 8.04) and 0.29 (± 1.99), respectively. The V5 values were significantly higher than V10 (P-value < 0.001) and V30 (P-value < 0.001), while V10 and V30 did not differ significantly (P-value = 0.155). Conclusions: This study reveals distinct dosimetric patterns for the cervical and thoracic esophagus during RT. The thoracic esophagus received low radiation doses, whereas the cervical esophagus demonstrated higher doses and more significant variability. Findings emphasize the importance of meticulous treatment planning to minimize potential late radiation-induced complications, especially in the cervical region.
Keywords: Breast neoplasm, radiotherapy, esophagus, radiation dosimetry.
Full-Text [PDF 575 kb]   (355 Downloads)    
Type of Study: Short Report | Subject: Radiation Biology
References
1. 1. Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, et al. (2021) Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020. Cancer Communications, 41(11): 1183-1194. [DOI:10.1002/cac2.12207] [PMID] []
2. Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM (2020) Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study. The Lancet Global Health, 8(8): e1027-e37. [DOI:10.1016/S2214-109X(20)30215-1]
3. Moo T-A, Sanford R, Dang C, Morrow M (2018) Overview of breast cancer therapy. PET Clinics, 13(3): 339-354. [DOI:10.1016/j.cpet.2018.02.006] [PMID] []
4. Group EBCTC (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10 801 women in 17 randomised trials. The Lancet, 378(9804): 1707-1716. [DOI:10.1016/S0140-6736(11)61629-2] [PMID]
5. Group EBCTC (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet, 383(9935): 2127-2135. [DOI:10.1016/S0140-6736(14)60488-8]
6. Goldoost B, Jabbari N, Esnaashari O, Mostafanezhad K (2019) Evaluating the effects of esophageal and breast cancer radiotherapy on the cardiac function and determining the relationship between the dosimetric parameters and ejection fraction changes. International Journal of Radiation Research, 17(2): 237-244.
7. Noël G and Antoni D (2022) Organs at risk radiation dose constraints. Cancer/Radiothérapie, 26(1-2): 59-75. [DOI:10.1016/j.canrad.2021.11.001] [PMID]
8. Taylor CW, Wang Z, Macaulay E, Jagsi R, Duane F, Darby SC (2015) Exposure of the heart in breast cancer radiation therapy: A systematic review of heart doses published during 2003 to 2013. Int J Radiat Oncol Biol Phys, 93(4): 845-53. [DOI:10.1016/j.ijrobp.2015.07.2292] [PMID]
9. Lettmaier S, Kreppner S, Lotter M, Walser M, Ott OJ, Fietkau R, et al. (2011) Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: A dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy. Radiotherapy and Oncology, 100(2): 189-194. [DOI:10.1016/j.radonc.2010.07.011] [PMID]
10. Mohammed Amin SS, Faraj KA (2023) Estimation of oesophageal surface dose in breast cancer patients undergoing supraclavicular irradiation by thermoluminescent dosimeter (TLD) and treatment planning system (TPS). International Journal of Radiation Research, 21(4): 647-652. [DOI:10.61186/ijrr.21.4.647]
11. Mosleh-Shirazi MA, Sheikholeslami A, Fathipour E, Mohammadianpanah M, Ansari M, Karbasi S, et al. (2022) Equivalent uniform dose and normal tissue complication probability of acute esophagitis in head-and-neck radiotherapy: Sensitivity to dose calculation accuracy. International Journal of Radiation Research, 20(2): 447-454. [DOI:10.52547/ijrr.20.2.28]
12. Grantzau T and Overgaard J (2015) Risk of second non-breast cancer after radiotherapy for breast cancer: A systematic review and meta-analysis of 762,468 patients. Radiotherapy and Oncology, 114(1): 56-65. [DOI:10.1016/j.radonc.2014.10.004] [PMID]
13. Duane FK, Kerr A, Wang Z, Darby SC, Ntentas G, Aznar MC, et al. (2021) Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020. Radiotherapy and Oncology, 164: 261-267. [DOI:10.1016/j.radonc.2021.09.032] [PMID]
14. Hurkmans CW, Borger JH, Pieters BR, Russell NS, Jansen EP, Mijnheer BJ (2001) Variability in target volume delineation on CT scans of the breast. Int J Radiat Oncol Biol Phys, 50(5): 1366-1372. [DOI:10.1016/S0360-3016(01)01635-2]
15. Wang DQ, Zhang N, Dong LH, Zhong YH, Wu HF, Zhong QZ, et al. Dose-Volume predictors for radiation esophagitis in patients with breast cancer undergoing hypofractionated regional nodal radiation therapy. Int J Radiat Oncol Biol Phys.
16. West K, Schneider M, Wright C, Beldham‐Collins R, Coburn N, Tiver K, et al. (2020) Radiation‐induced oesophagitis in breast cancer: Factors influencing onset and severity for patients receiving supraclavicular nodal irradiation. Journal of Medical Imaging and Radiation Oncology, 64(1): 113-119. [DOI:10.1111/1754-9485.12943] [PMID]
17. Wang Q, Jie W, Liang Z, Wu H, Cheng J (2017) Postmastectomy intensity modulation radiated therapy of chest wall and regional nodes: Retrospective analysis of the performance and complications up for 5 years. Medicine, 96(39). [DOI:10.1097/MD.0000000000007956] [PMID] []
18. Lamart S, Stovall M, Simon SL, Smith SA, Weathers RE, Howell RM, et al. (2013) Radiation dose to the esophagus from breast cancer radiation therapy, 1943-1996: An international population-based study of 414 patients. Int J Radiat Oncol Biol Phys, 86(4): 694-701. [DOI:10.1016/j.ijrobp.2013.03.014] [PMID] []
19. Yaney A, Ayan AS, Pan X, Jhawar S, Healy E, Beyer S, et al. Dosimetric parameters associated with radiation-induced esophagitis in breast cancer patients undergoing regional nodal irradiation. Radiotherapy and Oncology, 155: 167-173. [DOI:10.1016/j.radonc.2020.10.042] [PMID]
20. Bhaskaran R, Pulickal SG, Reghu H, Perumangat A, Moolath GB (2023) Comparison of dose volumetric parameters of oesophagus in the radiation treatment of carcinoma breast with and without oesophagus delineation. Journal of Radiotherapy in Practice, 22: e10. [DOI:10.1017/S1460396921000467]

XML     Print

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 22, Issue 4 (10-2024) Back to browse issues page